Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular apoptosis pathway represents a highly regulated form of programmed cell death characterized by distinct morphological and biochemical changes including cell shrinkage, chromatin condensation, DNA fragmentation, and formation of apoptotic bodies[3]. The pathway operates through two main routes: the intrinsic (mitochondrial) pathway, initiated by intracellular stress signals such as DNA damage or growth factor deprivation[1][4], and the extrinsic pathway, triggered by external signals through death receptors like Fas and TNF receptors[3]. Both pathways converge on the activation of executioner caspases (particularly caspase-3, -6, and -7), which systematically degrade cellular components[5]. The intrinsic pathway involves the Bcl-2 family proteins that regulate mitochondrial outer membrane permeabilization, leading to cytochrome c release and apoptosome formation with Apaf-1 and procaspase-9[1]. The extrinsic pathway forms the death-inducing signaling complex (DISC) containing FADD and caspase-8[3]. A critical feature distinguishing apoptosis from necrosis is the externalization of phosphatidylserine on the cell surface, enabling recognition and phagocytic removal of apoptotic cells without inflammatory response[2][5]. In healthy adults, approximately 50 to 70 billion cells undergo apoptosis daily, playing essential roles in development, tissue homeostasis, and immunity[3]. Dysregulation of this pathway contributes to various diseases, with excessive apoptosis causing atrophy and insufficient apoptosis enabling cancer development[3].
Bcl-2 family modulation (promoting or inhibiting mitochondrial outer membrane permeabilization), Death receptor activation (extrinsic pathway initiation), Caspase activation or inhibition, IAP protein inhibition, p53 pathway activation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular apoptosis pathway (None).